Abbott posted its financial results for the second quarter, which ended June 30, showing a 2.6 percent decrease in net earnings--to $1.29 billion from $1.32 billion in the same period last year.

While the buzz surrounding bioabsorbable stents continues to build, there are new evolutions within drug-eluting stent (DES) technology that vendors say will soon (and already may) be available for the shelves of your cath lab

Guidewire technology over the past decade has greatly improved and most companies offer a comprehensive collection of various wires with different properties to help interventional cardiologists reach their vascular target in a timely, accurate and safe manner.

The Society of Interventional Radiology (SIR), which has previously published clinical practice guidelines on radiation dose management, has released a new document providing guidance on the safe use of fluoroscopy on pediatric and adult patients.

Coronary stent developer Stentys has secured the second tranche of its Series B financing from Sofinnova Partners and Scottish Equity Partners -- closing an additional $4.2 million investment from new investor Crdit Agricole Private Equity -- bringing the total B round financing to more than $22 million.

Terumo Interventional Systems has expanded its Pinnacle R/O II radiopaque marker introducer sheaths for vascular access, extending the range of interventional procedures performed by the technology.

Among high-risk STEMI patients, who were treated with fibrinolysis, transfer for PCI within six hours after fibrinolysis was associated with significantly fewer ischemic complications than was standard treatment, according to the TRANSFER-AMI trial results published in the June 25 issue in the New England Journal of Medicine.

AccessClosure has released its newest addition to the Mynx vascular closure family, the Mynx M5.